F. Jiménez

EFFECTS OF RISEDRONATE ON METABOLIC BONE DISEASE IN PATIENTS WITH TYPE 1 DIABETES AND OSTEOPOROSIS

J. D. Luna, F. Escobar-Jiménez, P. López-Ibarra, 2008 .

Implementation of clinical practice guidelines for acute ischaemic stroke in specialist care centres.

F. Jiménez, A. Cabello, J. D. L. H. Torres-Puchol, 2013 .

Relationship of plasma bone cytokines with hypercalcemia in cancer patients.

P. Esbrit, F. de Miguel, M. Jaras, 2000, Clinica chimica acta; international journal of clinical chemistry.

Comparison of two immunoradiometric assays for parathyroid hormone-related protein in the evaluation of cancer patients with and without hypercalcemia.

P. Esbrit, F. de Miguel, J. Hurtado, 1998, Clinica chimica acta; international journal of clinical chemistry.

Biochemical bone markers, bone mineral content, and bone mineral density in rats with experimental nephrotic syndrome.

B. Specker, J. Pedraza-Chaverri, R. Sierra, 1997, Renal failure.

Drug-related mortality among inpatients: a retrospective observational study

C. Rodríguez, F. Jiménez, A. Cabello, 2016, European Journal of Clinical Pharmacology.

Adrenal response in critically ill patients of the Hospital de Clínicas of Asuncion, Paraguay

M. Caceres, A. Fretes, E. Bueno, 2009 .

Burden of illness of Crohn's disease in Spain.

M. Artés, J. Alonso, F. J. Jiménez, 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.